๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
0.0371
+0.0042 (12.77%)
Nov 19, 2026, 1:54 PM CET

Immunovia AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.950.690.931.581.150.84
Revenue Growth
148.79%-26.42%-40.89%37.55%35.66%133.15%
Gross Profit
1.160.550.93-5.11-3.0715.81
Operating Income
-75.49-80.45-110.17-296.69-191.21-166.74
Net Income
-76.2-145.92-76.54-309.44-168.09-155.97
Earnings Per Share
-0.12-0.42-0.93-7.95-7.43-6.89
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.6277.4625.3276.79106.04287.41
Total Debt
2.930.860.6810.2737.5733.26
Net Cash (Debt)
16.6976.624.6466.5268.47254.14
Net Cash Growth
169.10%210.91%-62.96%-2.84%-73.06%-41.62%
Net Cash Per Share
0.030.220.301.713.0311.23

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-76.15-78.4-96.75-147.06-175.58-152.65
Capital Expenditures
-----1.26-3.1
Free Cash Flow
-76.15-78.4-96.75-147.06-176.84-155.75
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
59.40%80.15%100.00%--267.77%1873.58%
Operating Margin
-3865.08%-11744.82%-11833.94%-18837.27%-16699.48%-19756.04%
Pretax Margin
-3901.59%-21301.46%-8221.37%-19646.92%-14680.52%-18479.38%
Profit Margin
-3901.59%-21301.46%-8221.38%-19646.92%-14680.52%-18479.38%
FCF Margin
-3899.28%-11445.26%-10392.37%-9336.95%-15444.37%-18453.67%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.33222.9199.5350.95519.842011.10